F-Prime Capital Partners
Edit

F-Prime Capital Partners

http://www.fprimecapital.com/
Last activity: 11.04.2025
Active
Invests in categories: HealthTechPlatformDataFinTechLearnMedtechTechnologyCareServiceDrug
Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx.

Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.
News
2K
Portfolio
295
Persons
102
Mentions
211
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Investment Type: Venture Capital
Investment Stage: Seed; Series A; Series B; Series C

Portfolio 295

DateNameWebsiteTotal RaisedLocation
15.03.2025Tripsuitetripsuite.com$5MUnited Sta...
30.01.2025OXIOoxio.com$40MUnited Sta...
11.01.2025RhyGazerhygaze.com$94.27M-
11.01.2025Beadsbeads-hospice.jp-Japan, Fuk...
12.12.2024nChromaBionchromabio.com--
12.12.2024OncoveryCa...oncoverycare.com$4.5MUnited Sta...
05.12.2024Dinaridinari.com$7.5MUnited Sta...
05.12.2024LakeShore ...lakeshorebio.com-China, Bei...
05.12.2024Alternativ...abio-x.com--
05.12.2024KnowYourse...knowyourself.cc-China, Sha...
Show more

Persons 102

DateFirst NameLast NameTitleLinkedInLocation
-BetsyMuléSenior Ass...linkedin.c...-
-SarahLamontSenior Ass...linkedin.c...-
-BobbyGaspar, M....Venture Pa...linkedin.c...-
-ShervinGhaemmagha...Operating ...linkedin.c...-
-RobertWeisskoff,...Partner-
-KarenMohanDirector o...-
-IshaniGanguli, M...Venture Ad...-
-BenGormanVenture Pa...linkedin.c...-
-NikhilAnanthSenior Ass...linkedin.c...-
-MichelleGoodrich, ...Manager of...linkedin.c...-
Show more

News 2002

DateTitleDescription
19.03.2024Engrail closes $157M series B, fueled by investors’ renewed interest in neuropsychiatry-
19.03.2024Engrail Therapeutics raises $157 million in funding from F-Prime Capital, others-
19.03.2024Almaden Genomics and Elucidata Pair g.nome® with Polly-
19.03.2024CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)-
19.03.2024The World’s Most Innovative Companies of 2024-
19.03.2024Clover Health, Quartet Health team up against serious mental illness-
19.03.2024This company is dispensing a dose of visibility into drug availability-
18.03.2024FDA greenlights Orchard’s gene therapy Lenmeldy for rare and fatal disease-
14.03.2024HiLabs inputs $39M for medical data cleanup-
13.03.2024Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance-
Show more

Mentions in press and media 211

DateTitleDescription
12.04.2025Navigating the Digital Landscape: The Power of Seamless Transitions and Robust ProtectionIn the fast-paced world of technology, change is the only constant. Businesses are always on the lookout for tools that enhance efficiency and security. Enter MoEngage and McAfee, two giants in their respective fields, offering solutions th...
11.04.2025MoEngage Makes Migration Effortless with "MoUpgrade"SAN FRANCISCO, April 11, 2025 /PRNewswire/ -- Upgrading to an advanced cross-channel customer engagement platform can often seem time-consuming, costly, and full of operational challenges. That's why MoEngage is redefining the migration exp...
18.03.2025Patina Launches New Service, Patina Total Health (TM), to Make Personalized, Age-Friendly Care Accessible to Medicare Advantage MembersPatina Logo Patina's population health service to improve member experience, reduce total cost of care, improve quality and STAR ratings, and drive value-based outcomes at scale. PHILADELPHIA, March 18, 2025 /PRNewswire-PRWeb/ -- Patina, th...
13.02.2025OnCusp Therapeutics: A New Hope for Ovarian Cancer PatientsIn the realm of cancer treatment, hope often feels like a flickering candle in a storm. Yet, OnCusp Therapeutics is igniting that flame with its recent FDA Fast Track Designation for CUSP06, a promising therapy for platinum-resistant ovaria...
12.02.2025OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian CancerPRINCETON, N.J., Feb. 12, 2025 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients, tod...
29.01.2025Atalanta Therapeutics: A New Dawn in Neurological TreatmentsAtalanta Therapeutics is making waves in the biotech ocean. This Boston-based company has just secured $75 million in Series B funding, a lifeline for its ambitious plans to tackle neurological diseases. The funding round was led by EQT Lif...
28.01.2025Eleos secures $60M for behavioral health with AI agentsPhoto: LUIS ALVAREZ/Getty Images Eleos, an AI behavioral healthcare company, announced it raised $60 million in a Series C funding round, bringing its total raise to more than $120 million. The round was led by Greenfield Partners, with par...
28.01.2025EQT Life Sciences leads USD 97 million Series B in Atalanta Therapeutics, a biotech firm developing treatments for epilepsy and Huntington’s diseaseEQT Life Sciences leads USD 97 million Series B in Atalanta Therapeutics, a biotech firm developing treatments for epilepsy and Huntington’s disease Tue, Jan 28, 2025 13:00 CET Report this content Atalanta Therapeutics is pioneering RNA int...
27.01.2025Eleos: $60 Million (Series C) Raised For Transforming Behavioral Health Using AI AgentsEleos, a leader in AI for behavioral health, announced a $60 million Series C funding round led by Greenfield Partners, with participation from existing investors such as F-Prime Capital, Eight Roads, Menlo Ventures, and ION — and new ones,...
26.01.20251Money: Over $20 Million Raised To Develop Stablecoin Payments Network1Money, a company developing the world’s first purpose-built Layer 1 exclusively designed for stablecoins payments, emerged from stealth and announced over $20 million in funding. This seed funding round includes participation from financia...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In